For many diabetes, is an evil and treacherous disease. My walk with diabetes has been turbulent and overwhelming at times. Here are some memoirs of a clinical trial. I was thirteen years old and the Insulin Pump had recently surged to the forefront of diabetes therapy. Prior to then, I had been taking insulin by injection three to four times per day. Despite a hearty regiment of diet and exercise, my hemoglobin a1c would not fall below 8.0%. My best a1C was 8.3%.
A hemoglobin a1c measures the mean of blood glucose levels in any patient. For non-diabetics, a normal a1c ranges from 4.8% – 6%. 6% is considered a borderline case of a diabetic, in non-diabetic populations. For diabetics, the target now rests at below 7%. Any level above this figure, is indicative of poor control. The theory imposes that diabetics not stray to far from this figure. Every full percentage point above 7% exponentially increases the threat of diabetic complications to emerge. The American Diabetes Association and leading researchers tirelessly strive to find a way to quell and aid this chronic epidemic. The insulin pump emerged as a messianic invention.
Many doctors and professionals hypothesized that insulin pump therapy can lower any diabetic’s a1C by 1.0% within two years of beginning therapy. When I acquired my insulin pump, I was simply asked to log my a1c results over the course of two years and submit them to the American Diabetes Association. Hemoglobin a1c tests are to be administered every three months. The more frequent they are run, the more trends can be spotted and more progress can be noted.
Three months after I began my insulin pump therapy, I was met with staggering results. My a1c had dropped beyond 1.0%, it fell 1.7%. My new hemoglobin a1C was at 6.6%. At the time, it was the greatest day of my life. The adulation and ecstasy I felt was unparalleled. I have only felt greater euphoria with a pen in my hand and with the woman I love under my arm. The clinical trail ensued for another nine months. My best result was 6.2%, and thus the hypothesis was proven to be true. In the course of six months, let alone a year…the insulin pump dropped my hemoglobin a1c 2.0% points.
For those of you who may find apprehension and anxiety in completing a clinical trial, I would advise you to do it. I learned a lot about my illness from studying it extensively. The result of these trials inherently is the hope of providing the public with information that may spare them from the hideous clutches of any disorder or disease. This is no insidious observation period with inferences that bring terror and uncertainty. These medicinal studies have helped scientists develop new strategies to defeat these terrible diseases. Most importantly, you will learn about yourself. It is not solely focused on the disease’s effect on your life, but rather an insight in to the strength you have already had to endure it.